Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Cash from Investing Activities (2021 - 2025)

Historic Cash from Investing Activities for Krystal Biotech (KRYS) over the last 5 years, with Q4 2025 value amounting to $11.2 million.

  • Krystal Biotech's Cash from Investing Activities rose 11332.45% to $11.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$58.4 million, marking a year-over-year increase of 6425.76%. This contributed to the annual value of -$58.4 million for FY2025, which is 6425.76% up from last year.
  • According to the latest figures from Q4 2025, Krystal Biotech's Cash from Investing Activities is $11.2 million, which was up 11332.45% from -$4.3 million recorded in Q3 2025.
  • Krystal Biotech's Cash from Investing Activities' 5-year high stood at $105.2 million during Q3 2023, with a 5-year trough of -$126.5 million in Q4 2021.
  • Its 5-year average for Cash from Investing Activities is -$24.0 million, with a median of -$17.7 million in 2023.
  • In the last 5 years, Krystal Biotech's Cash from Investing Activities crashed by 738433.73% in 2022 and then surged by 81350.47% in 2023.
  • Krystal Biotech's Cash from Investing Activities (Quarter) stood at -$126.5 million in 2021, then surged by 95.88% to -$5.2 million in 2022, then tumbled by 95.08% to -$10.2 million in 2023, then plummeted by 724.59% to -$83.8 million in 2024, then skyrocketed by 113.32% to $11.2 million in 2025.
  • Its last three reported values are $11.2 million in Q4 2025, -$4.3 million for Q3 2025, and -$10.5 million during Q2 2025.